Bronchopulmonary oxalosis revealing pulmonary aspergillosis in an immunocompetent patient: a case report Authors: Soufiane Abdouh, Mouad Gourti, Imane Sellam, Mohsine Makloul, El Mehdi Maidi Published: 2026 ABSTRACT AbstractBronchopulmonary oxalosis refers to localized calcium oxalate crystal deposition in pulmonary tissue associated with aspergillosis. Several Aspergillus species produce oxalic acid that precipitates with tissue calcium, and resulting crystals can cause local tissue injury. We report a 19-year-old Moroccan female without known immunodeficiency or underlying lung disease who presented with a thin-walled cystic pulmonary lesion with air-fluid level, initially suspected to represent a hydatid cyst. Following surgical resection, histopathology revealed abundant calcium oxalate crystals, supporting the diagnosis of pulmonary aspergillosis with prominent bronchopulmonary oxalosis. Clinicians should consider aspergillosis when evaluating unexplained cystic lesions with identified calcium oxalate crystals. Introduction Aspergillus thrives in soil and other harsh habitats and has evolved traits that enable it to persist in diverse conditions [1]. In humans, this ubiquitous mold causes a spectrum of pulmonary diseases collectively termed pulmonary aspergillosis that range from saprophytic colonization and aspergilloma to chronic and invasive forms, most commonly in immunocompromised individuals [2]. Pathologists recognize calcium oxalate deposition within the lung parenchyma as a supportive histopathologic clue for infection with oxalate-producing Aspergillus species [3]. We report an unusual case of an immunocompetent young Moroccan female in whom histopathologic evaluation of a cystic lung lesion biopsy specimen identified pulmonary aspergillosis with prominent calcium oxalate crystal deposition. Case presentation A previously healthy 19-year-old Moroccan female presented with a 6-month history of right-sided chest pain, progressive dyspnea, intermittent fever, and productive cough with clear sputum. She had no history of recurrent infections, tobacco use, animal exposure, or travel outside Morocco. On examination, she appeared comfortable and afebrile (37.6°C), but tachycardic (heart rate 120 beats per minute), respiratory rate 19 breaths per minute, oxygen saturation 98% on room air, and blood pressure 110/60 mmHg. Chest examination revealed dullness to percussion, diminished breath sounds, and reduced tactile fremitus over the right lower lung field. No lymphadenopathy was detected. Chest radiography (Fig. 1) and computed tomography (Fig. 2) demonstrated a thin-walled cystic lesion in the lower right lobe with an air-fluid level. Given the patient’s age, geographic location, and imaging features, radiologists favored a diagnosis of pulmonary hydatid cyst. Chest radiograph showing right lower lobe cystic lesion with air-fluid level. Chest CT-scan showing right lower lobe cystic lesion with air-fluid level. Laboratory investigations are summarized in Table 1. Initial work-up, including hydatid cyst serology and tuberculosis screening was unremarkable, raising doubt about the initial diagnosis. Table 1Laboratory investigations.TestResultReference RangeHematologyWhite blood cell count,/mm359304000–10 000Neutrophils,/mm319931500–7000Lymphocytes,/mm332791000–4000Monocytes,/mm3492200–800Eosinophils,/mm31480–500Hemoglobin, g/dl12.612–16Platelets, ×103/mm3285150–400Inflammatory markerCRP, mg/l15.2a<10Liver Function TestsAspartate aminotransferase, U/l2810–40Alanine aminotransferase, U/l327–56Renal FunctionCreatinine, mg/dl0.70.5–1.0MetabolicFasting glucose, mg/dl8870–100Hemoglobin A1c, %5.2<5.7SerologyHydatid cyst antibody (ELISA)Negative—HIV antibodyNegative—QuantiFERON-TB GoldNegative— Aspergillus antibody (IgG)Positive—MicrobiologyLung biopsy cultureNegative—CRP, C-reactive protein; ELISA, enzyme-linked immunosorbent assay; HIV, human immunodeficiency virus aMildly elevated on admission, normalized before discharge Laboratory investigations. CRP, C-reactive protein; ELISA, enzyme-linked immunosorbent assay; HIV, human immunodeficiency virus aMildly elevated on admission, normalized before discharge The patient underwent surgical exploration. Intraoperatively, we encountered a large cavity containing a friable, tan-colored mass rather than the expected hydatid membrane. Pathologic examination revealed granulation tissue with extensive necrosis and hemorrhage. Microscopy demonstrated a thickened cystic wall, polymorphic inflammatory infiltrate, dilated bronchial structures (Fig. 3), and abundant calcium oxalate crystals (Fig. 4). H&E stain (×100) light microscopy showing dilated bronchus with irregular thickening of the bronchial wall. H&E stain (×200) light microscopy highlighting calcium oxalate crystals arranged in rosettes (black arrows). Intraoperative lung biopsy specimens were sent for mycological culture, which returned negative after standard incubation. However, the unexpected finding of calcium oxalate crystals prompted targeted serologic testing for Aspergillus-specific IgG antibodies, which returned positive. Comprehensive immunodeficiency evaluation, including screening for diabetes and HIV, was negative. Taken together, these findings supported a diagnosis of chronic pulmonary aspergillosis. We initiated oral itraconazole 200 mg twice daily. At 6-month follow-up, she remained asymptomatic with complete radiologic resolution and no complications (Table 2). Table 2Timeline of clinical course.Time PointKey FindingsT0: Admission6-month history of chest pain, dyspnea, fever, coughCXR/CT: right lower lobe, thin-walled cystic lesion with air-fluid levelLabs: CRP 15.2 mg/l; hydatid serology negativeT1: Surgical resectionCavity with friable tan massHistopathology: calcium oxalate crystalsT2: Extended work-up Aspergillus antibody positiveHIV, diabetes screening negativeItraconazole 200 mg twice daily initiatedT3: Follow-up at six monthsAsymptomatic, complete radiologic resolutionNo complications Timeline of clinical course. Discussion Nime and Hutchins first described the association between bronchopulmonary oxalosis and aspergillosis in 1973 [4]. Several Aspergillus species produce oxalic acid as a fermentation byproduct, formed through enzymatic hydrolysis of oxaloacetate by oxaloacetate acetylhydrolase [3]. These crystals can damage localized tissue and blood vessels independently of direct hyphal invasion, triggering foreign-body inflammation and mechanical injury to surrounding parenchyma [3, 5]. A. niger is most strongly associated with visible oxalosis and accounts for approximately 45% of aspergillosis cases with detectable crystals, followed by A. flavus (16%), while A. fumigatus rarely produces visible calcium oxalate deposition [6]. Calcium oxalate crystals appear birefringent under polarized light, arranged in rosettes or wheat-sheaf patterns [6]. Detection of crystals with classic morphology in sputum or bronchoalveolar lavage specimens demonstrates high specificity for Aspergillus infection in reported cohorts [6]. Clinicians should examine sputum, bronchial washings, and lung biopsies for crystals when suspecting aspergillosis, particularly if initial cultures are negative [5, 6]. Aspergillosis in patients without recognized systemic immunosuppression reflects local pulmonary defense failure rather than systemic immunodeficiency [7]. Chronic pulmonary aspergillosis develops when the lungs have structural damage that fails to physically eliminate Aspergillus, such as pulmonary tuberculosis, chronic obstructive pulmonary disease, bronchiectasis, or other lung diseases that create niches where fungi evade immune surveillance [7, 8]. Disease progression in non-neutropenic patients with structural lung disease typically follows a more indolent course compared to invasive aspergillosis in profoundly immunosuppressed hosts [8, 9]. Recent reports indicate that pulmonary oxalosis remains an uncommon but diagnostically valuable clue to pulmonary aspergillosis, most often described in association with aspergilloma, invasive disease, or oxalic acid-producing species such as A. niger [10, 11]. In previously reported cases, oxalate deposition typically occurs in patients with underlying structural lung abnormalities, including prior tuberculosis, bronchiectasis, or chronic lung diseases [3, 9–11]. In contrast, our case involves a young patient without documented immunodeficiency or pre-existing pulmonary pathology, thereby expanding the recognized clinical spectrum of aspergillosis-associated oxalosis. This observation supports emerging evidence that pulmonary aspergillosis can occasionally develop in immunocompetent individuals without classic risk factors [9]. Management should be guided by the specific aspergillosis syndrome rather than by oxalate crystal presence alone. For invasive pulmonary aspergillosis, guideline-based first-line therapy consists of voriconazole, with isavuconazole or amphotericin B formulations as alternatives [2]. For chronic pulmonary aspergillosis, long-term oral triazole therapy is typically employed [12]. Surgical resection should be considered for symptomatic patients, particularly those with recurrent or life-threatening hemoptysis when localized disease amenable to lobectomy or lesser resection is present and operative risk is acceptable [13]. Calcium oxalate crystal detection serves as a valuable diagnostic adjunct supporting the diagnosis of aspergillosis, but does not independently determine antifungal selection or surgical indication [5, 6]. Treatment response should be assessed through clinical improvement, serial imaging, and microbiologic monitoring where feasible. Conclusion This case demonstrates that bronchopulmonary oxalosis can reveal aspergillosis even in young immunocompetent patients without documented underlying lung disease. Detection of calcium oxalate crystals with characteristic rosette or wheat-sheaf morphology provided a valuable diagnostic clue that, combined with clinical and radiologic findings, guided empiric antifungal therapy while awaiting microbiologic confirmation. Clinicians evaluating unexplained thin-walled cystic lesions should consider aspergillosis when calcium oxalate crystals are identified, particularly when initial cultures are unrevealing.